scholarly journals Ways to prevent acute viral infection and its bacterial complications

2021 ◽  
pp. 103-109
Author(s):  
G. V. Lavrenova ◽  
M. S. Zaynchukovskiy ◽  
K. T. Zhamakochyan ◽  
M. I. Malysheva
Keyword(s):  
Respiratory Tract ◽  
Viral Infection ◽  
Viral Infections ◽  
Chronic Sinusitis ◽  
Inflammatory Diseases ◽  
Pathological Process ◽  
The Body ◽  
Stress Factors ◽  
Upper Respiratory Tract ◽  
Starting Point

Viruses of the ARVI group that are tropic to the epithelium of the upper respiratory tract are able to inhibit the function of the mucociliary system to a certain extent, which contributes to the attachment of bacterial infection. Thus, in respiratory inflammatory diseases, the infection is often combined. This means, that the question about approaches to treatment at the stage of prevention of the development of complications of ARVI arises. A significant increase in the relapse of chronic sinusitis has been observed over the past 10 years. According to A.I. Kryukov et al. the relapse of inflammatory diseases of the paranasal sinuses, the chronic process has no tendency to decrease, aided by the unfavorable ecological situation, the growth of allergic and viral respiratory diseases, poor nutrition to which the body is not evolutionarily adapted. Worsening of chronic sinusitis contributes to many factors, but the starting point is almost always viral infections. Relapse, as a rule, begins with viral rhinitis, which is rarely an independent disease. Most often, a runny nose is a symptom of ARVI or ARI (influenza, parainfluenza, adenovirus infection, etc.). The entrance gate of infection is the epithelial cells of the respiratory tract. The main pathological process in sensitive cells develops both as a result of the penetration of the virus from the outside, and due to the activation of latent or chronic viral infection under the influence of various factors, including other infection.The appointment of drugs with anti-inflammatory, immunomodulatory, adaptogenic activity is one of the promising options for the prevention of both primary viral infection and the development of bacterial complications.We have included a drug that combines adaptogenic and immunomodulatory activities in the treatment of chronic sinusitis. Trekrezan belongs to the group of adaptogens – low-toxic compounds, it is recommended as a measure for the treatment and prevention of viral infections and increasing resistance to various stress factors (hypoxia, hypothermia) and adverse environmental effects. 

scholarly journals 335 The Gut-Lung Axis: The Human Perspective

2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 69-70
Author(s):  
Michael Surette
Keyword(s):  
Respiratory Tract ◽  
Early Life ◽  
Inflammatory Diseases ◽  
Chronic Inflammatory Disease ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Targeted Interventions ◽  
Susceptibility To Infection ◽  
Airway Diseases ◽  
Asthma And Allergy

Abstract The human gastrointestinal tract is the largest immune organ in the body and consequently influences the overall immune state of all body sites. The gut also harbors the largest proportion of the microbiome. In early life, the maturation of the microbiome and immune system are closely entangled, forming a homeostatic system that imparts individuality and stability to the host microbiome. It is now well established that factors that affect early life gut microbiota modulate susceptibility to chronic inflammatory diseases, including airway diseases such as asthma and allergy. Despite this global influence of the gut on immune response in the lungs, local microbiome-immune interactions also shape the response and susceptibility to disease in the airways. The upper respiratory tract and lung microbiomes also contribute to acute and chronic airway diseases. Modulating the gut-lung axis as well as respiratory tract through microbiome-targeted interventions to promote health and reduce susceptibility to infection and chronic inflammatory disease may represent an effective strategy, particularly in early and late life.

scholarly journals New prospects for local etiotropic treatment of acute respiratory viral infections

2019 ◽  
pp. 105-108
Author(s):  
A. A. Krivopalov ◽  
V. A. Shatalov ◽  
S. V. Shervashidze
Keyword(s):  
Respiratory Tract ◽  
Respiratory System ◽  
Safety Profile ◽  
Viral Infections ◽  
Inflammatory Diseases ◽  
Upper Respiratory Tract ◽  
Positive Experience ◽  
High Efficacy ◽  
Upper Respiratory ◽  
Respiratory Viral Infections

According to WHO, the respiratory system diseases are currently inside the ten most common pathologies. The modern strategy for treating influenza and ARVI gives priority to the antiviral and immunostimulating agents, but the symptomatic drugs, which include preparations based on silver and its compounds, also play an important role. The large positive experience in using silver preparations supported by numerous clinical studies shows their high efficacy and satisfactory safety profile in the treatment of infectious and inflammatory diseases of the nose and upper respiratory tract in children and adults.

scholarly journals Modern possibilities of herbal medicine in the treatment of acute inflammatory diseases of the upper respiratory tract

2021 ◽  
pp. 127-133
Author(s):  
A. V. Gurov ◽  
A. V. Muzhichkova
Keyword(s):  
Phenolic Compounds ◽  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Plant Materials ◽  
Pelargonium Sidoides ◽  
Medicinal Substances ◽  
Upper Respiratory ◽  
Tract Infections

The article provides data on the effectiveness of the use of the drug in the treatment of acute, chronic and recurrent diseases of the respiratory tract and ENT organs. The drug is an extract of Pelargonium sidoides. From the standpoint of modern pharmacology, it is known that the use of natural products based on plant materials ensures safety and the absence of pronounced side effects. The main active ingredients of pelargonium are phenolic compounds: coumarins, flavonoids and phenolic acids. The article details the biochemical and pharmacological properties of each of the above groups of compounds. It has been shown that the presence of several classes of phenolic compounds simultaneously contributes to the potentiation of the pharmacological effects of each group separately. Therefore, drug has a pronounced polytropic effect: antiviral, antibacterial, immunomodulatory, mucolytic, anti-inflammatory, antioxidant, cytoprotective. The article presents the results of numerous domestic and foreign randomized, placebo-controlled studies demonstrating its high efficacy and safety in the treatment of ENT diseases, upper respiratory tract infections and bronchitis, not only in adults, but also in children over 1 year old. On the basis of the analyzed and presented material, the authors concluded that the use of a natural-based drug in the treatment of acute respiratory infection is effective and safe, both as monotherapy and in combination with other medicinal substances. He is able to quickly eliminate not only the symptoms of inflammation, but also to support the body with any ailments of this type.

scholarly journals Time-course of upper respiratory tract viral infection and COPD exacerbation

2019 ◽  
Vol 54 (4) ◽  
pp. 1900407 ◽  
Author(s):  
Daiana Stolz ◽  
Eleni Papakonstantinou ◽  
Leticia Grize ◽  
Daniel Schilter ◽  
Werner Strobel ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Viral Infection ◽  
Respiratory Tract Infections ◽  
Viral Infections ◽  
Nucleic Acid Amplification ◽  
Chronic Obstructive ◽  
Upper Respiratory Tract ◽  
Stable Period ◽  
Upper Respiratory ◽  
Tract Infections

Viral respiratory tract infections have been implicated as the predominant risk factor for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). We aimed to evaluate, longitudinally, the association between upper respiratory tract infections (URTI) caused by viruses and AECOPD.Detection of 18 viruses was performed in naso- and orοpharyngeal swabs from 450 COPD patients (Global Initiative for Chronic Obstructive Lung Disease stages 2–4) who were followed for a mean of 27 months. Swabs were taken during stable periods (n=1909), at URTI onset (n=391), 10 days after the URTI (n=356) and during an AECOPD (n=177) and tested using a multiplex nucleic acid amplification test.Evidence of at least one respiratory virus was significantly higher at URTI onset (52.7%), 10 days after the URTI (15.2%) and during an AECOPD (38.4%), compared with the stable period (5.3%, p<0.001). During stable visits, rhinovirus accounted for 54.2% of all viral infections, followed by coronavirus (20.5%). None of the viruses were identified in two consecutive stable visits. Patients with a viral infection at URTI onset did not have a higher incidence of exacerbation than patients without viral infection (p=0.993). Τhe incidence of any viral infection during an AECOPD was similar between URTI-related AECOPD and non-URTI-related AECOPD (p=0.359). Only 24% of the patients that had a URTI-related AECOPD had the same virus at URTI onset and during an AECOPD. Detection of parainfluenza 3 at URTI onset was associated with a higher risk of an AECOPD (p=0.003). Rhinovirus and coronavirus were the most frequently detected viruses during AECOPD visits, accounting for 35.7% and 25.9% of all viral infections, respectively.The prevalence of viral infection during the stable period of COPD was low. The risk of exacerbation following the onset of URTI symptoms depends on the particular virus associated with the event and was significant only for parainfluenza 3.

scholarly journals Using of topical bacterial lysates in modern clinical practice

2021 ◽  
pp. 49-56
Author(s):  
V. M. Svistushkin ◽  
G. N. Nikiforova ◽  
A. V. Zolotova ◽  
V. A. Stepanova
Keyword(s):  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
Human Microbiome ◽  
Allergic Diseases ◽  
The Body ◽  
Economic Consequences ◽  
Medical Community ◽  
Side Reactions ◽  
Upper Respiratory Tract ◽  
Bacterial Lysates

Acute and chronic infectious and inflammatory diseases of the upper respiratory tract occupy a leading position in the structure of the pathology of the world’s population and remain the most frequent reason for patients seeking medical care. The prevalence and frequency of this disease in this nosological group makes a decisive contribution to the structure of the causes of temporary disability, which entails significant negative social and economic consequences. In this aspect, the spread of resistance of pathogens to etiotropic drugs and the insufficient arsenal of pathogenetic drugs stimulate the medical community to search for alternative approaches to the treatment of patients with respiratory pathology. One of these therapeutic areas is the use of immunomodulators, the most commonly used group of which are bacterial lysates. In the modern literature, sufficiently convincing data have been accumulated on the effectiveness of the use of bacterial lysates of systemic action, as a result of which the immune cells of the gastrointestinal tract are activated, which in turn leads to the restoration of autoregulation of the immune response throughout the body, and a decrease in the frequency of infectious and allergic diseases. The latest developments of domestic pharmacologists are topical bacterial lysates, the principle of which is based on the local activation of mucosal immunity in the respiratory tract. The undoubted advantage is that bacterial lysates, with all their effectiveness, do not harm the human microbiome, practically do not cause side reactions, combine well with other drugs, and can also be used at any stage of the disease, including for prophylactic purposes.

scholarly journals Possibilities of using multidirectional immunomodulators for acute and recurrent infectious and inflammatory diseases of the upper respiratory tract

2021 ◽  
pp. 89-95
Author(s):  
S. V. Morozova ◽  
L. V. Selezneva
Keyword(s):  
Immune System ◽  
Respiratory Tract ◽  
Respiratory Diseases ◽  
Inflammatory Diseases ◽  
Mechanisms Of Action ◽  
Biologically Active ◽  
Upper Respiratory Tract ◽  
Starting Point ◽  
Upper Respiratory

In many countries, with the prevention of acute respiratory diseases in children and adults, the use of various types of biologically active substances of natural and synthetic origin, called immunostimulants of various mechanisms of action, has been introduced. The purpose of this article is to provide a useful overview of main roles of available immunostimulants and their potential for use in inflammatory diseases of the upper respiratory tract. The article discusses aspects of the clinical use of immunomodulatory drugs in acute and recurrent infectious and inflammatory diseases of the respiratory tract (SARS-CoV-2 included). The mechanisms of action of immunomodulators on the immune system are briefly outlined. On the drug Imunorix the evidence base of mechanisms of correction of the immune system in respiratory diseases of the upper respiratory tract is given, as well as the analysis of the clinical efficacy of drug. The use of immunostimulator to increase the level of immunoglobulins (IgA, IgM, IgG) and subpopulations of T-lymphocytes (CD3 +, CD4 +). Also, the use of the drug has shown its usefulness in the appointment of antibacterial drugs in the treatment of upper respiratory tract infectious diseases. This article also provides an overview of recent clinical studies of drug. Researchers from various countries have tried to better clarify and define the mechanisms of action of immunostimulator both in vitro and in vivo. Of course, the improvement in research methodology over the past 20 years, and the acquired knowledge in various areas of clinical immunology, should become the starting point for further research on the drug. Randomized controlled trials of the trial use of the drug in the prevention of acute respiratory infections.

scholarly journals Several studies on the problem of management patients with chronic tonsillitis during periods of remission and exacerbation

2020 ◽  
pp. 109-115
Author(s):  
A. Yu. Ovchinnikov ◽  
N. A. Miroshnichenko ◽  
Yu. O. Nikolaeva ◽  
M. M. Vasilyev
Keyword(s):  
Respiratory Tract ◽  
Randomized Clinical Trials ◽  
Inflammatory Diseases ◽  
Allergic Diseases ◽  
Lymphatic Drainage ◽  
The Body ◽  
Chronic Tonsillitis ◽  
Upper Respiratory Tract ◽  
Bacterial Strains ◽  
Upper Respiratory

Increase in the number of acute and chronic diseases is a global trend. On the one hand, the emergence of new types of viruses, their active mutation, an increase in antibiotic-resistant bacterial strains, a high frequency of immunodeficiency and allergic diseases contribute to this. On the other hand is inadequate treatment of inflammatory diseases of the upper respiratory tract, widespread use of systemic antibiotics without indications. The use of bioregulatory medicines with proven efficacy in the complex treatment can reduce the drug load on the body, reduce the bacterial complications and side effects. Traumeel®S joins the physiological course of inflammation and activates pro-resolving mediators, contributes to its faster completion and tissue repair. The efficacy and safety of Traumeel®S has been confirmed in many randomized clinical trials. The drug has proven its value in almost any inflammatory pathology of the upper respiratory tract and ear. The drug Lymphomyosot®, a multicomponent agent with lymphatic drainage action, has proven itself perfectly in the complex therapy of chronic tonsillitis. In November 2019, the Council of Experts of the National Medical Association of Otorhinolaryngologists on the problems of pathology of the lympharyngeal ring was held. It is recommended to use the multicomponent bioregulatory preparation Traumeel®S to correct the inflammatory process, which has shown in studies a modulating effect on inflammatory mediators without suppressing COX-2 (prostaglandins). With exacerbation of chronic tonsillitis and lymphadenitis of nonspecific etiology, it is possible to use the multicomponent preparation Lymphomyosot®, which helps to improve the drainage and detoxification function of the lymphatic system.

scholarly journals EFFECT OF PARENTERAL INFLUENZA VACCINATION ON THE CELL COMPOSITION AND ITS MICROBIOTA OF THE OROPHARYNGEAL SECRETION IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES OF THE UPPER RESPIRATORY TRACT

2021 ◽  
Vol 17 (3) ◽  
pp. 38-43
Author(s):  
M.D. Timchenko ◽  
S.V. Timchenko ◽  
L.I. Volosevich
Keyword(s):  
Respiratory Tract ◽  
Influenza Vaccination ◽  
Viral Infections ◽  
Inflammatory Diseases ◽  
Temporary Increase ◽  
Upper Respiratory Tract ◽  
Microbial Composition ◽  
Chronic Inflammatory Diseases ◽  
Cell Composition ◽  
Upper Respiratory

Relevance. Until recently, the issues of changes in immunological and microbiological parameters of the oropharynx in vaccinated against viral infections remain insufficiently covered. Objective: to determine the effect of parenteral influenza vaccination on the cellular and microbial composition of the oropharyngeal secretion in patients with chronic inflammatory diseases of the upper respiratory tract with the presence of anamnestic antibodies to vaccine strains of viruses. Materials and methods. Oropharyngeal secretion samples of 18 patients with chronic inflammatory diseases of the upper respiratory tract studied before and 3, 12, and 36 weeks after vaccination with inactivated split influenza vaccine. As control 25 donors were used. The cell composition of the sediment was determined. A microbiological study of the oropharyngeal secretion was performed. Results. At 3 and 12 weeks after vaccination, vaccinated patients significantly changed the relative rates of entry into the oropharyngeal secretion of lymphocytes and the composition of its microbiota while maintaining its total number. After 36 weeks, the cell composition and the representation of pathogenic and opportunistic microflora practically returned to baseline with a significant increase in the total microbiota. Conclusions. Parenteral administration of inactivated split vaccine to persons with chronic inflammatory diseases of the upper respiratory tract with the presence in the blood of anamnestic antibodies to vaccine strains of viruses is accompanied by a simultaneous temporary increase in lymphocyte representation with a simultaneous decrease in the number of transfusion microflora in the oropharyngeal secretion.

scholarly journals Phytotherapy in treatment and rehabilitation of children recovering from acute respiratory viral infections

2016 ◽  
Vol 1 (1) ◽  
pp. 58-62 ◽  
Author(s):  
O. V. Goncharova
Keyword(s):  
Respiratory Tract ◽  
Viral Infections ◽  
Inflammatory Diseases ◽  
Herbal Medicines ◽  
Upper Respiratory Tract ◽  
Upper Respiratory ◽  
Respiratory Viral Infections

Challenges of cough pharmacotherapy in the treatment of acute respiratory viral infections in children are specific and determined by the nature of cough, its duration and so on. Herbal medicines (extract of plantain and thyme) are feasible for the treatment of cough not only in acute inflammatory diseases of the upper respiratory tract but also in the period of recovery/rehabilitation. The combination of herbal medicines and special exercises improve the condition of children after acute respiratory viral infections.

scholarly journals Species composition of certain strains of microorganisms in the development of upper respiratory tract disease in agricultural workers

2021 ◽  
Vol 100 (11) ◽  
pp. 1261-1266
Author(s):  
Lyaylya M. Masyagutova ◽  
Lilia G. Gizatullina ◽  
Maxmuza K. Gainullina ◽  
Natalya V. Vlasova ◽  
Linara A. Rafikova ◽  
...  
Keyword(s):  
Pseudomonas Aeruginosa ◽  
Respiratory Tract ◽  
Agricultural Production ◽  
Inflammatory Diseases ◽  
The Body ◽  
Antibacterial Drug ◽  
Upper Respiratory Tract ◽  
E Coli ◽  
Leading Role ◽  
Upper Respiratory

Introduction. Microbiocenosis is a self-regulating system of relationships between the body and microflora. Ensuring the technological process of agricultural production involves contact with conditionally pathogenic and pathogenic microflora. The spread of antibacterial drug resistance is a matter of concern. Materials and methods. There was studied the microbiocenosis of the upper respiratory tract in agricultural enterprises: in the absence of inflammatory diseases; the clinical picture of diseases of the ENT organs, and the susceptibility of the isolated strains to antibacterial drugs. Results. Working conditions of employees correspond to classes 3.1 - 3.3. Typical representatives are strains of Streptococcus, Staphylococcus, Micrococcus, Neisseria, Corynebacterium. The etiological share of S. Aureus, C. Albicans, E. Coli, Kl. Pneumoniae, Ps. Aeruginosa, predominates in the formation of inflammatory diseases. Staphylococcus are most susceptible to Cefotaxime and Sparfloxacin, followed by Cefepime, Levofloxacin and Amikacin. Strains of Kl. pneumoniae are susceptible to Cefotaxime and Sparfloxacin; strains of Pseudomonas aeruginosa - to Cefepime and Ceftazidim; C. Albicans and C. crusei - to Amphotericin B and Fluconazole. Conclusion. The complex industrial factors of agricultural production contributes to the violation of the ratio of microbial associations even against the background of clinical health, which is a risk factor for the development of inflammatory processes. S. Aureus strains; Candida Albicans; Klebsiella Pneumoniae play the leading role. Pseudomonas aeruginosa and E. Coli. The isolates demonstrate multidrug resistance to antimicrobial drugs.

Sign in / Sign up

Export Citation Format

Share Document